1. |
Okano M,Kawa K,Kimura H,et al.Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection[J].Am J Hematol,2005,80(1):64-69.
|
2. |
Kimura H,Hoshino Y,Kanegane H,et al.Clinical and virologic characteristics of chronic active Epstein-Barr virus infection[J].Blood,2001,98(2):280-286.
|
3. |
Kimura H,Morishima T,Kanegane H,et al.Prognostic factors for chronic active Epstein-Barr virus infection[J].J Infect Dis,2003,187(4):527-533.
|
4. |
洪亮,金嘉琳,张文宏,等.成人慢性活动性EB病毒感染三例分析[J].中华临床感染病杂志,2012,5(2):101-103.
|
5. |
段红梅,谢正德,申昆玲.慢性活动性EB病毒感染的研究进展[J].临床儿科杂志,2007,25(2):153-156.
|
6. |
Yamashita N,Kimura H,Morishima T.Virological aspects of Epstein-Barr virus infections[J].Acta Med Okayama,2005,59(6):239-246.
|
7. |
宋红梅,吴晓燕,王薇,等.严重慢性活动性EB病毒感染12例临床回顾与随访[J].中华儿科杂志,2009,47(9):682-686.
|
8. |
Okano M.Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome[J].Crit Rev Oncol Hematol,2002,44(3):273-282.
|
9. |
Cohen JI.Optimal treatment for chronic active Epstein-Barr virus diseases[J].Pediatr Transplant,2009,13(4):393-396.
|
10. |
Gulley ML,Glaser SL,Craig FE,et al.Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma[J].Am J Clin Pathol,2002,117(2):259-267.
|
11. |
de Boer M,Mol MJ,Bogman MJ,et al.Chronic active Epstein-Barr virus infection in an adult with no detectable immune deficiency[J].Neth J Med,2003,61(11):376-382.
|
12. |
Gershburg E,Pagano JS.Epstein-Barr virus infections:prospects for treatment[J].J Antimicrob Chemother,2005,56(2):277-281.
|
13. |
Sakai Y,Ohga S,Tonegawa Y,et al.Interferon-alpha therapy for chronic active Epstein-Barr virus infection:potential effect on the development of T-lymphoproliferative disease[J].J Pediatr Hematol Oncol,1998,20(4):342-346.
|
14. |
Fujisaki T,Nagafuchi S,Okamura T.Gamma-interferon for severe chronic active Epatein-Barr virus[J].Ann Intern Med,1993,118(6):474-475.
|
15. |
Kawa-Ha K,Franco E,Doi S,et al.Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2[J].Lancet,1987,1(8525):154.
|
16. |
Kimura H.Pathogenesis of chronic active Epstein-Barr virus infection:Is this an infectious disease,lymphoproliferative disorder,or immunodeficiency [J].Rev Med Virol,2006,16(4):251-261.
|
17. |
Imashuku S,Hibi S,Ohara T,et al.Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy[J].Blood,1999,93(6):1869-1874.
|
18. |
Okamura T,Hatsukawa Y,Arai H,et al.Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation[J].Lancet,2000,356(9225):223-224.
|
19. |
Uehara T,Nakaseko C,Hara S,et al.Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection[J].Am J Hematol,2004,76(4):368-372.
|
20. |
Okamura T,Kishimoto T,Inoue M,et al.Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease[J].Bone Marrow Transplant,2003,31(2):105-111.
|
21. |
Miyamura T,Chayama K,Wada T,et al.Two cases of chronic active Epstein-Barr virus infection in which EBV-specific cytotoxic T lymphocyte was induced after allogeneic bone marrow transplantation[J].Pediatr Transplant,2008,12(5):588-592.
|